Latest Regulatory News

Page 48 of 743
CSL Limited reported a sharp 80% drop in net profit for the half year ended December 2025, driven by significant restructuring and impairment charges, yet maintained its growth guidance and dividend payout.
Ada Torres
Ada Torres
11 Feb 2026
Commonwealth Bank of Australia’s latest Basel III Pillar 3 disclosures reveal steady capital adequacy ratios and proactive adaptation to evolving regulatory standards as of December 2025.
Claire Turing
Claire Turing
11 Feb 2026
Commonwealth Bank of Australia reported a robust half-year result for December 2025, with a 6% rise in cash NPAT to $5.445 billion and a 10-cent dividend increase, underpinned by disciplined growth and strong capital management.
Claire Turing
Claire Turing
11 Feb 2026
Commonwealth Bank of Australia reported a 5% rise in net profit for the half-year ended December 2025, balancing lending growth with margin pressures and increased technology investment.
Victor Sage
Victor Sage
11 Feb 2026
Commonwealth Bank of Australia reported a 5% increase in statutory net profit after tax to $5.367 billion for the half year ended December 2025, supported by lending growth and improved credit quality despite margin pressures and higher expenses. The bank declared a fully franked interim dividend of $2.35 per share.
Claire Turing
Claire Turing
11 Feb 2026
Elanor Investors Group has secured securityholder approval for a $125 million recapitalisation with Rockworth Capital Partners and the acquisition of Firmus Capital, marking a pivotal step in stabilising its balance sheet and positioning for growth.
Eva Park
Eva Park
10 Feb 2026
GreenX Metals has successfully completed a A$13.6 million placement while confirming Poland’s appeal against a Singapore court ruling, underscoring ongoing legal challenges alongside fresh capital.
Maxwell Dee
Maxwell Dee
10 Feb 2026
EMC Gold has responded to an ASX price query following a sudden spike in its share price, confirming no undisclosed information exists and affirming compliance with continuous disclosure rules.
Maxwell Dee
Maxwell Dee
10 Feb 2026
Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.
Ada Torres
Ada Torres
10 Feb 2026
Electro Optic Systems (EOS) has firmly rejected allegations from a recent Grizzly Research report, highlighting its strengthened financial position, significant contract wins, and strategic acquisition to bolster its defence technology portfolio.
Victor Sage
Victor Sage
10 Feb 2026
Orbminco Limited has issued 62.5 million shares to raise $1 million as part of a staged capital raising, with shareholder approval for the next tranche expected in March.
Maxwell Dee
Maxwell Dee
10 Feb 2026
Brightstar Resources has launched a $5 million Share Purchase Plan offering eligible shareholders discounted shares to fund key mining projects. The offer opens on 10 February and closes on 27 February 2026.
Maxwell Dee
Maxwell Dee
10 Feb 2026